
Rite Aid, based in New Jersey, has filed for Chapter 11 bankruptcy protection and unveiled its plans for a comprehensive debt reduction through restructuring.
The company has reached an agreement with its creditors on a restructuring strategy, which involves a careful evaluation of its retail locations, with an emphasis on closing underperforming stores.
To support this restructuring initiative, Rite Aid has secured the commitment of lenders to provide $3.45 billion in new funding, ensuring the necessary liquidity.
Rite Aid, facing challenges such as declining sales, significant debt, and numerous lawsuits linking the company to the opioid epidemic, has taken this step to address its financial difficulties, CNBC reported.
In the most recent quarter ending on June 3, the company’s revenue dropped to $5.65 billion, down from $6.01 billion in the same period the previous year.
The net loss also widened to $306.7 million, equivalent to $5.56 per share, compared to a net loss of $110.2 million, or $2.03 per share, in the corresponding period of the previous year.
Following this challenging quarter, Rite Aid adjusted its fiscal 2024 forecast and alerted investors to anticipate a full-year loss in the range of $650 million to $680 million, with the fiscal year ending in late February.
Despite its retail pharmacy segment serving as a significant growth driver, Rite Aid has been unable to offset its increasing losses.
Written by staff
